How many studies have been conducted on Inosine Pranobex?

BiohacksAI has indexed 100 PubMed studies on Inosine Pranobex, including 13 randomized controlled trials (RCTs). 54% of studies involve human subjects.

What are the main research areas for Inosine Pranobex?

The primary research domains for Inosine Pranobex are 🛡️ Immunity, 🔬 Oncology, 🔬 Inflammation. This is based on analysis of 100 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Inosine Pranobex

An alkylamino-alcohol complex of inosine used in the treatment of a variety of viral infections. Unlike other antiviral agents, it acts by modifying or stimulating cell-mediated immune processes rather than acting on the virus directly.

100+ PubMed studies analyzed · 13 RCTs · Evidence Score: 49.9

Research Domains

Inosine Pranobex has been studied across 14 research domains including 🛡️ Immunity, 🔬 Oncology, 🔬 Inflammation, 🫁 Respiratory, 🧠 Focus & Attention. The primary research focus is 🛡️ Immunity with 18% of studies addressing this area.

Loading evidence profile...

This evidence profile for Inosine Pranobex is generated deterministically from 100 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.